Back to BAKER BROS. ADVISORS LP

CTMX
4 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in CYTOMX THERAPEUTICS INC.

BAKER BROS. ADVISORS LP holds 5M shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $23.4M as of 2026-Q1. The position was increased (+17.1% shares). CTMX represents 0.1% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$23.4M

Current Shares

5M

Total Value Change

+$15.5M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
5M
+17.1%
$23.4M0.1%$4.81
40
2025-Q4
Unchanged
4.3M
0.0%
$18.1M0.1%$4.16
0
2025-Q3
Increased
4.3M
+22.0%
$13.6M0.1%$3.23
34
2025-Q2
New
3.5M
-
$7.9M0.1%$2.25
38

Other major holders of CTMX: FMR LLC, Point72 Asset Management, L.P., BANK OF AMERICA CORP /DE/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used